Eli Lilly First Pharma to Reach $1 Trillion Market Cap
Eli Lilly makes pharmaceutical history as first company to achieve $1 trillion market capitalization after shares rose 1.7% on November 21, 2025. Learn what this means for investors.
Eli Lilly makes pharmaceutical history as first company to achieve $1 trillion market capitalization after shares rose 1.7% on November 21, 2025. Learn what this means for investors.
Mid and small cap companies delivered stronger Q2 results than large caps, with better revenue growth and operating performance. Discover which sectors led this impressive performance.
Indian mutual fund investors are diversifying portfolios with flexi-cap and mid-cap funds, shifting from large-cap and small-cap investments. AMFI data reveals significant inflow changes and strong mid-cap fund performance.
Uttar Pradesh accelerates toward $1 trillion economy goal with rapid project implementation and policy reforms. Discover how the state is transforming its economic landscape.
Eli Lilly's Alzheimer's drug donanemab gets Indian regulatory approval. The treatment slows cognitive decline by 35.1% and could be available next year. Learn about its benefits and pricing.
Eli Lilly's Alzheimer's drug donanemab gets Indian regulator nod. The treatment slows cognitive decline by 35.1% and is expected to launch in India next year. Details on pricing and safety.
Novo Nordisk reduces Wegovy's price to $349 and prepares an aggressive launch for its oral weight-loss pill to combat competition from Eli Lilly and expand patient access.
Silicon Valley VCs chase first $1 trillion unicorn as AI boom transforms investment strategies. Learn how Nvidia's $4 trillion success fuels this high-stakes race.
Anish Tawakley of ICICI Prudential AMC states India's macro setup is strong. Demand softness is a cyclical challenge. He shares views on earnings, trade deals, and preferred sectors. Read more for expert investment insights.
Cobra Kai's Jacob Bertrand reveals if his character Hawk's iconic back tattoo is real. Discover the show's fashion impact and fan reactions. Read more!
PPFAS AMC, known for its successful flexi-cap fund, enters the competitive large-cap space with Parag Parikh Large Cap Fund. Will their valuation-conscious approach work?
Discover three promising mid-cap and small-cap water infrastructure stocks poised for growth in India's rapidly expanding water management market. Learn about their financial performance and expansion plans.
Discover how flexi-cap mutual funds performed over 5 years. Learn why past returns matter but don't guarantee future performance. Consult SEBI advisors before investing.
Tesla shareholders approve Elon Musk's nearly $1 trillion compensation package. The billionaire celebrated by dancing with Optimus humanoid robot at annual meeting. Read more about this historic deal.
Indian rupee declined 15 paise to 88.65 against US dollar in early trade Wednesday, reversing Tuesday's gains amid global market volatility. Track live forex updates.
Donald Trump warns Supreme Court that reversing his tariff policy could cost $3 trillion. Learn how this landmark case could reshape US trade authority and economic security.
Trump administration secures obesity drug price cuts with Eli Lilly and Novo Nordisk. Medicare coverage expansion opens 30 million patient market starting April 2026. Read analysis.
Marcellus Investment expert Arindam Mandal explains why US stocks aren't in bubble territory and why Indian large-caps may see earnings recovery. Key insights on FII trends and Fed impact.
Indian rupee slips 2 paise against US dollar, settling at 88.65. Explore key factors driving currency movement including foreign fund outflows, crude oil prices, and domestic equity trends.
Tesla shareholders approve historic compensation package for Elon Musk. Discover the mind-boggling possibilities of what $1 trillion can purchase in today's world.
Indian rupee experiences minor decline against US dollar in early trading, influenced by foreign fund outflows and strengthening American currency. Expert analysis on market trends.
Tesla's board revives Elon Musk's massive compensation package that could make him the world's first trillionaire. Discover the details of this groundbreaking deal and what it means for Tesla's future.
Former President Donald Trump reveals groundbreaking agreement with pharmaceutical giants to dramatically reduce costs of popular weight loss medications, promising relief for millions struggling with obesity.
In a major victory for American patients, pharmaceutical titans Eli Lilly and Novo Nordisk announce significant price reductions for popular weight-loss medications after Trump's intervention.
Nobel Prize-winning economists Esther Duflo and Abhijit Banerjee weigh in on Elon Musk's record-breaking compensation package, questioning whether astronomical pay actually improves executive performance.
Indian rupee strengthens against US dollar, closing at 83.86 with 10 paise gain. Discover key factors driving this upward trend including foreign fund inflows and domestic equity performance.
Sam Altman's OpenAI pushes for US government backing to accelerate massive AI infrastructure investments, aiming to overcome energy and chip challenges in global AI race.
Tesla investors are set for a crucial vote on Elon Musk's unprecedented compensation package that could reach $1 trillion in value. The November 6 decision marks a pivotal moment for corporate governance and executive pay in the tech industry.
Discover why this undervalued small-cap IT stock is creating massive buzz with 30% gains in just three trading sessions. Expert analysis reveals whether this rally has legs or if it's just market hype.
Indian rupee strengthens against US dollar in early trading session, supported by positive domestic equity markets and foreign fund inflows. Get latest forex updates and market analysis.